arrow
I

Ian A. Strohbehn

University of Vermont
H指数:21
被引数:3,440

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response to Letter to the Editor, Re: The Effect of Nirmatrelvir-Ritonavir on Short- and Long-term Adverse Outcomes From COVID-19 Among Patients With Kidney Disease: A Propensity Score-Matched Study Open Forum Infect Dis. 2024 Dec 31;12(1):ofae756. doi: 10.1093/ofid/ofae756

致编辑的信回复,关于:在肾病患者中,Nirmatrelvir-Ritonavir对COVID-19短期和长期不良结局的影响:一项倾向性评分匹配研究《感染性疾病开放论坛》。2024年12月31日;12(1):ofae756。doi:10.1093/ofid/ofae756

2025-09-010
OAAI
Sarcopenia, adiposity and large discordance between cystatin C and creatinine-based estimated glomerular filtration rate in patients with cancer
2024-04-222
OA
Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer
2022-10-016
OAAI
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
2022-02-0118
OAAI
Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation
2022-02-0112
OA
Immune-related adverse events and kidney function decline in patients with genitourinary cancers treated with immune checkpoint inhibitors
2021-11-0112
PRE